Elevance Health

ELV Market Outlook

NateF

Not Invested

Community Contributor

Published

31 Dec 24

Updated

08 Jan 25

NateF's Fair Value

US$390.54

18.9% undervalued

08 Jan

US$316.55

-42.0%

2.3%

Author's Valuation

US$390.5

18.9% undervalued

NateF's Fair Value

Narrative

Updates1

Shared on05 Jan 25

NateF made no meaningful changes to valuation assumptions.

NateF'sFair Value

US$390.5

18.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

6.29%

Healthcare Services revenue growth rate

0.26%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.78%

Calculation

US$8.91b

Earnings '29

13.33x

PE Ratio '29

US$118.81b

Market Cap '29

US$118.81b

Market Cap '29

217.32m

No. shares '29

US$546.70

Share Price '29

US$546.70 Share Price '29

Discounted to 2024 @ 5.92% p.a.

US$410.15

Fair Value '24